Altimmune ALT
NASDAQ ALT
$2.73 -0.03 (-1.09%)
As of: Oct 2, 2026 · 11:38 AM EDT

Altimmune (ALT) Long-Term Investments (2026)

Updated

Altimmune (ALT) recorded Long-Term Investments of $192.25 million in Q2 2026.

Analysis

Altimmune (ALT) Long-Term Investments (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 266.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.22 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 69.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 2.62 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.56 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.79 Bn
10 Altimmune 556.20 Mn 556.20 Mn - 192.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 192.25 Mn
API Access

Altimmune Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=ALT&period=max&api_key=YOUR_API_KEY